High Flux Dialysers - مدی تک سیستم

KOA	Surface Area (m2)	Blood priming Volume (ml)	Clearances at QB 200/300 (ml/min)					UF Coefficient (Ultrafiltration)(ml/mmHg.h)	Type
KOA	Surface Area (m2)	Blood priming Volume (ml)	Inulin	Vitamine B12	Phosphate	Creatinine	Urea	UF Coefficient (Ultrafiltration)(ml/mmHg.h)	Type
59	1/0	72/78	105/118	156/186	168/205	184/246	778	32	PS 100 HF
69	1/3	86/95	120/135	170/205	175/221	189/251	836	43	PS 130 HF
86	1/6	108/120	142/165	183/233	191/252	195/270	1145	55	PS 160 HF
105	1/8	116/131	149/176	187/242	193/260	196/275	1265	59	PS 180 HF
72	1/3	99/107	136/156	177/221	186/241	191/257	916	54	PES 130 HF
89	1/6	111/124	148/172	184/237	191/254	194/271	1167	62	PES 160 HF
110	1/8	118/133	153/180	179/245	195/263	198/277	1321	78	PES 180 HF

Performance data measured in vitro according to standard ISO 8637

QB = 200/300 ml/min, QF=0 mi/min, T=37 c

LF= Low Flux, HF= High Flux

Purema

Unique process technology influence separation profile of membrane formation

Thicker separation
Sharpened sieving profile (S.E.T)
Optimized dialysate side distribution
Higher mechanical strength resulting in
Low albumin loss
High middle molecule removal
Maximum low molecular clearance

Undulation

P.E.T. :

Performance Enhancing Technology

PET (Polyethylene terephthalate) spacer yarns consist of multifilament threads integrated into the fiber bundles

Improves dialysate distribution throughout the dialyzer

Increases clearance values
Maintains consistent performance

Throughout the entire treatment

From dialyser to dialyser

S.E.T.- Active surface management PUREMA blood

side surface

S.E.T stands for sieving Enhancing Technology

Unique patented process technology

Thicker separation layer
Unchanged ultrafiltration
More uniform pore distribution
Active surface management

Steeper sieving curve

More selective removal

Doc. Code: F72300RD01

Rev. No: R28

Date of Issue: 01/Jan/2020

KOA	Surface Area (m2)	Blood priming Volume (ml)	Clearances at QB 200/300 (ml/min)					UF Coefficient (Ultrafiltration)(ml/mmHg.h)	Type
KOA	Surface Area (m2)	Blood priming Volume (ml)	Inulin	Vitamine B12	Phosphate	Creatinine	Urea	UF Coefficient (Ultrafiltration)(ml/mmHg.h)	Type
59	1/0	72/78	105/118	156/186	168/205	184/246	778	32	PS 100 HF
69	1/3	86/95	120/135	170/205	175/221	189/251	836	43	PS 130 HF
86	1/6	108/120	142/165	183/233	191/252	195/270	1145	55	PS 160 HF
105	1/8	116/131	149/176	187/242	193/260	196/275	1265	59	PS 180 HF
72	1/3	99/107	136/156	177/221	186/241	191/257	916	54	PES 130 HF
89	1/6	111/124	148/172	184/237	191/254	194/271	1167	62	PES 160 HF
110	1/8	118/133	153/180	179/245	195/263	198/277	1321	78	PES 180 HF

Performance data measured in vitro according to standard ISO 8637

QB = 200/300 ml/min, QF=0 mi/min, T=37 c

LF= Low Flux, HF= High Flux

Purema

Unique process technology influence separation profile of membrane formation

Thicker separation
Sharpened sieving profile (S.E.T)
Optimized dialysate side distribution
Higher mechanical strength resulting in
Low albumin loss
High middle molecule removal
Maximum low molecular clearance

Undulation

P.E.T. :

Performance Enhancing Technology

PET (Polyethylene terephthalate) spacer yarns consist of multifilament threads integrated into the fiber bundles

Improves dialysate distribution throughout the dialyzer

Increases clearance values
Maintains consistent performance

Throughout the entire treatment

From dialyser to dialyser

S.E.T.- Active surface management PUREMA blood

side surface

S.E.T stands for sieving Enhancing Technology

Unique patented process technology

Thicker separation layer
Unchanged ultrafiltration
More uniform pore distribution
Active surface management

Steeper sieving curve

More selective removal

Doc. Code: F72300RD01

Rev. No: R28

Date of Issue: 01/Jan/2020

KOA	Surface Area (m2)	Blood priming Volume (ml)	Clearances at QB 200/300 (ml/min)					UF Coefficient (Ultrafiltration)(ml/mmHg.h)	Type
KOA	Surface Area (m2)	Blood priming Volume (ml)	Inulin	Vitamine B12	Phosphate	Creatinine	Urea	UF Coefficient (Ultrafiltration)(ml/mmHg.h)	Type
59	1/0	72/78	105/118	156/186	168/205	184/246	778	32	PS 100 HF
69	1/3	86/95	120/135	170/205	175/221	189/251	836	43	PS 130 HF
86	1/6	108/120	142/165	183/233	191/252	195/270	1145	55	PS 160 HF
105	1/8	116/131	149/176	187/242	193/260	196/275	1265	59	PS 180 HF
72	1/3	99/107	136/156	177/221	186/241	191/257	916	54	PES 130 HF
89	1/6	111/124	148/172	184/237	191/254	194/271	1167	62	PES 160 HF
110	1/8	118/133	153/180	179/245	195/263	198/277	1321	78	PES 180 HF

Performance data measured in vitro according to standard ISO 8637

QB = 200/300 ml/min, QF=0 mi/min, T=37 c

LF= Low Flux, HF= High Flux

Purema

Unique process technology influence separation profile of membrane formation

Thicker separation
Sharpened sieving profile (S.E.T)
Optimized dialysate side distribution
Higher mechanical strength resulting in
Low albumin loss
High middle molecule removal
Maximum low molecular clearance

Undulation

P.E.T. :

Performance Enhancing Technology

PET (Polyethylene terephthalate) spacer yarns consist of multifilament threads integrated into the fiber bundles

Improves dialysate distribution throughout the dialyzer

Increases clearance values
Maintains consistent performance

Throughout the entire treatment

From dialyser to dialyser

S.E.T.- Active surface management PUREMA blood

side surface

S.E.T stands for sieving Enhancing Technology

Unique patented process technology

Thicker separation layer
Unchanged ultrafiltration
More uniform pore distribution
Active surface management

Steeper sieving curve

More selective removal

Doc. Code: F72300RD01

Rev. No: R28

Date of Issue: 01/Jan/2020

KOA	Surface Area (m2)	Blood priming Volume (ml)	Clearances at QB 200/300 (ml/min)					UF Coefficient (Ultrafiltration)(ml/mmHg.h)	Type
KOA	Surface Area (m2)	Blood priming Volume (ml)	Inulin	Vitamine B12	Phosphate	Creatinine	Urea	UF Coefficient (Ultrafiltration)(ml/mmHg.h)	Type
59	1/0	72/78	105/118	156/186	168/205	184/246	778	32	PS 100 HF
69	1/3	86/95	120/135	170/205	175/221	189/251	836	43	PS 130 HF
86	1/6	108/120	142/165	183/233	191/252	195/270	1145	55	PS 160 HF
105	1/8	116/131	149/176	187/242	193/260	196/275	1265	59	PS 180 HF
72	1/3	99/107	136/156	177/221	186/241	191/257	916	54	PES 130 HF
89	1/6	111/124	148/172	184/237	191/254	194/271	1167	62	PES 160 HF
110	1/8	118/133	153/180	179/245	195/263	198/277	1321	78	PES 180 HF

Performance data measured in vitro according to standard ISO 8637

QB = 200/300 ml/min, QF=0 mi/min, T=37 c

LF= Low Flux, HF= High Flux

Purema

Unique process technology influence separation profile of membrane formation

Thicker separation
Sharpened sieving profile (S.E.T)
Optimized dialysate side distribution
Higher mechanical strength resulting in
Low albumin loss
High middle molecule removal
Maximum low molecular clearance

Undulation

P.E.T. :

Performance Enhancing Technology

PET (Polyethylene terephthalate) spacer yarns consist of multifilament threads integrated into the fiber bundles

Improves dialysate distribution throughout the dialyzer

Increases clearance values
Maintains consistent performance

Throughout the entire treatment

From dialyser to dialyser

S.E.T.- Active surface management PUREMA blood

side surface

S.E.T stands for sieving Enhancing Technology

Unique patented process technology

Thicker separation layer
Unchanged ultrafiltration
More uniform pore distribution
Active surface management

Steeper sieving curve

More selective removal

Doc. Code: F72300RD01

Rev. No: R28

Date of Issue: 01/Jan/2020

KOA	Surface Area (m2)	Blood priming Volume (ml)	Clearances at QB 200/300 (ml/min)					UF Coefficient (Ultrafiltration)(ml/mmHg.h)	Type
KOA	Surface Area (m2)	Blood priming Volume (ml)	Inulin	Vitamine B12	Phosphate	Creatinine	Urea	UF Coefficient (Ultrafiltration)(ml/mmHg.h)	Type
59	1/0	72/78	105/118	156/186	168/205	184/246	778	32	PS 100 HF
69	1/3	86/95	120/135	170/205	175/221	189/251	836	43	PS 130 HF
86	1/6	108/120	142/165	183/233	191/252	195/270	1145	55	PS 160 HF
105	1/8	116/131	149/176	187/242	193/260	196/275	1265	59	PS 180 HF
72	1/3	99/107	136/156	177/221	186/241	191/257	916	54	PES 130 HF
89	1/6	111/124	148/172	184/237	191/254	194/271	1167	62	PES 160 HF
110	1/8	118/133	153/180	179/245	195/263	198/277	1321	78	PES 180 HF

Performance data measured in vitro according to standard ISO 8637

QB = 200/300 ml/min, QF=0 mi/min, T=37 c

LF= Low Flux, HF= High Flux

Purema

Unique process technology influence separation profile of membrane formation

Thicker separation
Sharpened sieving profile (S.E.T)
Optimized dialysate side distribution
Higher mechanical strength resulting in
Low albumin loss
High middle molecule removal
Maximum low molecular clearance

Undulation

P.E.T. :

Performance Enhancing Technology

PET (Polyethylene terephthalate) spacer yarns consist of multifilament threads integrated into the fiber bundles

Improves dialysate distribution throughout the dialyzer

Increases clearance values
Maintains consistent performance

Throughout the entire treatment

From dialyser to dialyser

S.E.T.- Active surface management PUREMA blood

side surface

S.E.T stands for sieving Enhancing Technology

Unique patented process technology

Thicker separation layer
Unchanged ultrafiltration
More uniform pore distribution
Active surface management

Steeper sieving curve

More selective removal

Doc. Code: F72300RD01

Rev. No: R28

Date of Issue: 01/Jan/2020

KOA	Surface Area (m2)	Blood priming Volume (ml)	Clearances at QB 200/300 (ml/min)					UF Coefficient (Ultrafiltration)(ml/mmHg.h)	Type
KOA	Surface Area (m2)	Blood priming Volume (ml)	Inulin	Vitamine B12	Phosphate	Creatinine	Urea	UF Coefficient (Ultrafiltration)(ml/mmHg.h)	Type
59	1/0	72/78	105/118	156/186	168/205	184/246	778	32	PS 100 HF
69	1/3	86/95	120/135	170/205	175/221	189/251	836	43	PS 130 HF
86	1/6	108/120	142/165	183/233	191/252	195/270	1145	55	PS 160 HF
105	1/8	116/131	149/176	187/242	193/260	196/275	1265	59	PS 180 HF
72	1/3	99/107	136/156	177/221	186/241	191/257	916	54	PES 130 HF
89	1/6	111/124	148/172	184/237	191/254	194/271	1167	62	PES 160 HF
110	1/8	118/133	153/180	179/245	195/263	198/277	1321	78	PES 180 HF

Performance data measured in vitro according to standard ISO 8637

QB = 200/300 ml/min, QF=0 mi/min, T=37 c

LF= Low Flux, HF= High Flux

Purema

Unique process technology influence separation profile of membrane formation

Thicker separation
Sharpened sieving profile (S.E.T)
Optimized dialysate side distribution
Higher mechanical strength resulting in
Low albumin loss
High middle molecule removal
Maximum low molecular clearance

Undulation

P.E.T. :

Performance Enhancing Technology

PET (Polyethylene terephthalate) spacer yarns consist of multifilament threads integrated into the fiber bundles

Improves dialysate distribution throughout the dialyzer

Increases clearance values
Maintains consistent performance

Throughout the entire treatment

From dialyser to dialyser

S.E.T.- Active surface management PUREMA blood

side surface

S.E.T stands for sieving Enhancing Technology

Unique patented process technology

Thicker separation layer
Unchanged ultrafiltration
More uniform pore distribution
Active surface management

Steeper sieving curve

More selective removal

Doc. Code: F72300RD01

Rev. No: R28

Date of Issue: 01/Jan/2020

KOA	Surface Area (m2)	Blood priming Volume (ml)	Clearances at QB 200/300 (ml/min)					UF Coefficient (Ultrafiltration)(ml/mmHg.h)	Type
KOA	Surface Area (m2)	Blood priming Volume (ml)	Inulin	Vitamine B12	Phosphate	Creatinine	Urea	UF Coefficient (Ultrafiltration)(ml/mmHg.h)	Type
59	1/0	72/78	105/118	156/186	168/205	184/246	778	32	PS 100 HF
69	1/3	86/95	120/135	170/205	175/221	189/251	836	43	PS 130 HF
86	1/6	108/120	142/165	183/233	191/252	195/270	1145	55	PS 160 HF
105	1/8	116/131	149/176	187/242	193/260	196/275	1265	59	PS 180 HF
72	1/3	99/107	136/156	177/221	186/241	191/257	916	54	PES 130 HF
89	1/6	111/124	148/172	184/237	191/254	194/271	1167	62	PES 160 HF
110	1/8	118/133	153/180	179/245	195/263	198/277	1321	78	PES 180 HF

Performance data measured in vitro according to standard ISO 8637

QB = 200/300 ml/min, QF=0 mi/min, T=37 c

LF= Low Flux, HF= High Flux

Purema

Unique process technology influence separation profile of membrane formation

Thicker separation
Sharpened sieving profile (S.E.T)
Optimized dialysate side distribution
Higher mechanical strength resulting in
Low albumin loss
High middle molecule removal
Maximum low molecular clearance

Undulation

P.E.T. :

Performance Enhancing Technology

PET (Polyethylene terephthalate) spacer yarns consist of multifilament threads integrated into the fiber bundles

Improves dialysate distribution throughout the dialyzer

Increases clearance values
Maintains consistent performance

Throughout the entire treatment

From dialyser to dialyser

S.E.T.- Active surface management PUREMA blood

side surface

S.E.T stands for sieving Enhancing Technology

Unique patented process technology

Thicker separation layer
Unchanged ultrafiltration
More uniform pore distribution
Active surface management

Steeper sieving curve

More selective removal

Doc. Code: F72300RD01

Rev. No: R28

Date of Issue: 01/Jan/2020

KOA	Surface Area (m2)	Blood priming Volume (ml)	Clearances at QB 200/300 (ml/min)					UF Coefficient (Ultrafiltration)(ml/mmHg.h)	Type
KOA	Surface Area (m2)	Blood priming Volume (ml)	Inulin	Vitamine B12	Phosphate	Creatinine	Urea	UF Coefficient (Ultrafiltration)(ml/mmHg.h)	Type
59	1/0	72/78	105/118	156/186	168/205	184/246	778	32	PS 100 HF
69	1/3	86/95	120/135	170/205	175/221	189/251	836	43	PS 130 HF
86	1/6	108/120	142/165	183/233	191/252	195/270	1145	55	PS 160 HF
105	1/8	116/131	149/176	187/242	193/260	196/275	1265	59	PS 180 HF
72	1/3	99/107	136/156	177/221	186/241	191/257	916	54	PES 130 HF
89	1/6	111/124	148/172	184/237	191/254	194/271	1167	62	PES 160 HF
110	1/8	118/133	153/180	179/245	195/263	198/277	1321	78	PES 180 HF

Performance data measured in vitro according to standard ISO 8637

QB = 200/300 ml/min, QF=0 mi/min, T=37 c

LF= Low Flux, HF= High Flux

Purema

Unique process technology influence separation profile of membrane formation

Thicker separation
Sharpened sieving profile (S.E.T)
Optimized dialysate side distribution
Higher mechanical strength resulting in
Low albumin loss
High middle molecule removal
Maximum low molecular clearance

Undulation

P.E.T. :

Performance Enhancing Technology

PET (Polyethylene terephthalate) spacer yarns consist of multifilament threads integrated into the fiber bundles

Improves dialysate distribution throughout the dialyzer

Increases clearance values
Maintains consistent performance

Throughout the entire treatment

From dialyser to dialyser

S.E.T.- Active surface management PUREMA blood

side surface

S.E.T stands for sieving Enhancing Technology

Unique patented process technology

Thicker separation layer
Unchanged ultrafiltration
More uniform pore distribution
Active surface management

Steeper sieving curve

More selective removal

Doc. Code: F72300RD01

Rev. No: R28

Date of Issue: 01/Jan/2020

Contact Us

Purema

Undulation

P.E.T. :

Performance Enhancing Technology

S.E.T.- Active surface management PUREMA blood

side surface

Purema

Undulation

P.E.T. :

Performance Enhancing Technology

S.E.T.- Active surface management PUREMA blood

side surface

Purema

Undulation

P.E.T. :

Performance Enhancing Technology

S.E.T.- Active surface management PUREMA blood

side surface

Purema

Undulation

P.E.T. :

Performance Enhancing Technology

S.E.T.- Active surface management PUREMA blood

side surface

Purema

Undulation

P.E.T. :

Performance Enhancing Technology

S.E.T.- Active surface management PUREMA blood

side surface

Purema

Undulation

P.E.T. :

Performance Enhancing Technology

S.E.T.- Active surface management PUREMA blood

side surface

Purema

Undulation

P.E.T. :

Performance Enhancing Technology

S.E.T.- Active surface management PUREMA blood

side surface

Purema

Undulation

P.E.T. :

Performance Enhancing Technology

S.E.T.- Active surface management PUREMA blood

side surface

Click here to collaborate with us

links

Contacts

ACTIVITIES

© Meditechsys. All rights Reserved